Literature DB >> 1123429

The pathogenesis of arthritis associated with acute hepatitis-B surface antigen-positive hepatitis. Complement activation and characterization of circulating immune complexes.

J R Wands, E Mann, E Alpert, K J Isselbacher.   

Abstract

Circulating immune complexes were identified in cryoproteins isolated from serial samples of serum from six patients with acute viral hepatitis with and without arthritic symptoms. Cryoprecipitates were analyzed for the presence of hepatitis-B surface antigen (HBsAg) and hepatitis-B surface antibody (anti-HBs) by hemagglutination inhibition and hemagglutination. Complement components were detected by counter electrophoresis, and immunoglobulins were detected by gel diffusion. HBsAg, IgG, and IgM were identified in cryoprecipitates from all hepatitis patients, but were higher in concentration in patients with arthritis. Only cryoprecipitates from hepatitis patients with arthritis contained IgA and complement components C3, C4, and C5 as well as IgG and IgM, which disappear with resolution of the arthritis. The subtypes of IgG in these cryoprecipitates were predominantly the complement-fixing IgG1 and IgG3, HBsAg and anti-HBs were concentrated several-fold in the cryoprecipitates when compared to the serum concentration. Sequential studies in two patients demonstrated that the initial appearance of anti-HBs in the cryoprotein complex was associated with the detection in the complex of IgM suggesting a primary immune response to HBsAg. The C3 activator fragment (C3A) of the properdin complex was found in fresh serum obtained from three hepatitis patients with arthritis and not in uncomplicated hepatitis. The cryoprecipitable immune complexes from patients with arthritis converted C3PA in fresh normal sera to C3A in vitro whereas cryoprotein isolated from patients with uncomplicated hepatitis had no such effect. Thus, the transient appearance of circulating complement-fixing immune complexes in patients with the arthritis of acute hepatitis is associated with activation of both classical and alternate complement pathways and suggests that they play an important role in the pathogenesis of these serum sickness-like extrahepatic symptoms.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1123429      PMCID: PMC301837          DOI: 10.1172/JCI108022

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  An epidemic of serum hepatits studied under controlled conditions.

Authors:  G S MIRICK; R E SHANK
Journal:  Trans Am Clin Climatol Assoc       Date:  1959

2.  Pathogenesis of serum sickness.

Authors:  F J DIXON; J J VAZQUEZ; W O WEIGLE; C G COCHRANE
Journal:  AMA Arch Pathol       Date:  1958-01

3.  [A micro-method of immuno-electrophoresis].

Authors:  J J SCHEIDEGGER
Journal:  Int Arch Allergy Appl Immunol       Date:  1955

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 5.  Human immunoglobulins: classes, subclasses, genetic variants, and idiotypes.

Authors:  J B Natvig; H G Kunkel
Journal:  Adv Immunol       Date:  1973       Impact factor: 3.543

6.  Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane.

Authors:  B Combes; J Shorey; A Barrera; P Stastny; E H Eigenbrodt; A R Hull; N W Carter
Journal:  Lancet       Date:  1971-07-31       Impact factor: 79.321

7.  Role of immune complexes involving SH antigen in pathogenesis of chronic active hepatitis and polyarteritis nodosa.

Authors:  A M Prince; C Trepo
Journal:  Lancet       Date:  1971-06-26       Impact factor: 79.321

8.  Arthritis of hepatitis associated with Australia antigen.

Authors:  D K Onion; C S Crumpacker; B C Gilliland
Journal:  Ann Intern Med       Date:  1971-07       Impact factor: 25.391

9.  Antibody to hepatitis-associated antigen. Frequency and pattern of response as detected by radioimmunoprecipitation.

Authors:  H J Lander; P V Holland; H J Alter; R M Chanock; R H Purcell
Journal:  JAMA       Date:  1972-05-22       Impact factor: 56.272

10.  Viral hepatitis, type B (MS-2 strain). Detection of antibody after primary infection.

Authors:  J J Lander; J P Giles; R H Purcell; S Krugman
Journal:  N Engl J Med       Date:  1971-08-05       Impact factor: 91.245

View more
  45 in total

1.  Antibodies against hepatitis C virus in mixed cryoglobulinemia patients.

Authors:  C Ferri; F Greco; G Longombardo; P Palla; A Moretti; E Marzo; P V Fosella; G Pasero; S Bombardieri
Journal:  Infection       Date:  1991 Nov-Dec       Impact factor: 3.553

2.  Extrahepatic manifestations of acute hepatitis B virus infection.

Authors:  Matthew R Kappus; Richard K Sterling
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-02

3.  Immune complexes of hepatitis B surface antigen in the pathogenesis of periarteritis nodosa. A study of seven necropsy cases.

Authors:  T Michalak
Journal:  Am J Pathol       Date:  1978-03       Impact factor: 4.307

4.  Immune complex detection by immunofluorescence on polymorphonuclear leucocytes.

Authors:  J W Steffelaar; F J Ten Kate; M Nap; A J Swaak; C B De Graaffreitsma; E H Van Elven; T M Feltkamp-Vroom
Journal:  Clin Exp Immunol       Date:  1977-03       Impact factor: 4.330

5.  Arthritis as the main or only symptom of hepatitis B infection.

Authors:  C Pease; A Keat
Journal:  Postgrad Med J       Date:  1985-06       Impact factor: 2.401

6.  The association of cryoglobulinaemia with nodules, vasculitis and fibrosing alveolitis in rheumatoid arthritis and their relationship to serum C1q binding activity and rheumatoid factor.

Authors:  C C Erhardt; P Mumford; R N Maini
Journal:  Clin Exp Immunol       Date:  1979-12       Impact factor: 4.330

7.  Evidence for a disease specific antigen in circulating immune complexes in ankylosing spondylitis.

Authors:  C Bruneau; H Bonin
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

8.  Status of hepatitis B virus in the aetiology of uveitis in Great Britain.

Authors:  P I Murray; J Prasad; A H Rahi
Journal:  Br J Ophthalmol       Date:  1983-10       Impact factor: 4.638

9.  Circulating immune complexes in patients with Candida albicans infections.

Authors:  G Burges; H P Holley; G Virella
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

10.  Circulating immune complexes in patients with acute measles and rubella virus infections.

Authors:  B Ziola; G Lund; O Meurman; A Salmi
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.